Axon Neuroscience
PrivateLast Round
Grant
May 1, 2016
Total Funding Raised
$1.08M
Company Overview
Axon Neuroscience is a biotechnology company that develops disease-modifying immunotherapeutics designed to treat Alzheimer's disease and other tauopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axon Neuroscience Comparables
Compare Axon Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AC Immune SA | 80% | |
| Vaxxinity, Inc. | 77% | |
| Nuravax | 77% |
Axon Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2016 | ||||
| Grant | Nov 10, 2015 | ||||
| Grant | Nov 10, 2015 | ||||
| Grant | Jun 1, 2012 | ||||
| Grant | Apr 1, 2011 | ||||
Grant | Jan 1, 2011 |
Axon Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Directorate-General for Health and Food Safety | Grant |
| International Centre for Genetic Engineering and Biotechnology | Grant |
| EU Joint Programme – Neurodegenerative Disease Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2016
$490K grant received from Horizon 2020.
- Nov 10, 2015
$120K grant received from Marie Skłodowska-Curie Actions.
Axon Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axon Neuroscience's valuation, stock price, and market status.
Is Axon Neuroscience a public or private company?
Axon Neuroscience is a private company.
What is the current stock price of Axon Neuroscience?
Axon Neuroscience is a private company with no public stock price. No recent secondary market data is available.
How much is Axon Neuroscience worth (valuation)?
Valuation information for Axon Neuroscience is not publicly available.
Can I buy Axon Neuroscience stock?
Axon Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axon Neuroscience's last funding round?
Axon Neuroscience's most recent funding round was Grant on May 1, 2016.
Who are the main investors in Axon Neuroscience?
Key investors in Axon Neuroscience include European Union's Horizon 2020, Directorate-General for Health and Food Safety, International Centre for Genetic Engineering and Biotechnology, EU Joint Programme – Neurodegenerative Disease Research.
Will Axon Neuroscience IPO soon?
No public IPO plans have been announced for Axon Neuroscience.
How can I track Axon Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axon Neuroscience's secondary market activity and sign up for updates.